Rokhsareh Aghili, Iran
Endocrine Research Center, Institute of Endocrinology and Metabolism Iran University of Medical SciencesPresenter of 2 Presentations
TYPE 2 DIABETES: PATIENT EXPERIENCE OF CHRONIC ILLNESS CARE
Abstract
Background and Aims
We were to assess patient perception of chronic illness care in people with type 2 diabetes and to determine whether demographic variables, self-care behavior, as well as affective variables were related with perception of chronic illness care.
Methods
We conducted a secondary analysis of the previously published cross-sectional study in Iranian people with type 2 diabetes. Chronic illness care was assessed with the validated tool of patient assessment of chronic illness care (PACIC). Different aspects of care according with the chronic care model are measured on a scale of 1–5, with 5 being highest perception of care. The association between perception of chronic illness care and measured variables were tested using descriptive and bivariate statistics.
Results
Three hundred eighty participants completed the PACIC questionnaire (53.4% female, mean age: 54.73±8.0 years, mean PACIC score: 2.52±0.87). In univariate analysis considering PACIC score as the dependent variable, chronic illness care was inversely associated with level of education and distress, whereas, insulin treatment, wellbeing, family-social support and self-management were positively associated with chronic care (All p-value<0.05). In the multivariate forward stepwise logistic regression analysis, family-social support was positively related to chronic care while level of education, marital status, diabetes-related distress, and high density lipoprotein had significant negative relationship with PACIC score (All p-value<0.05).
Conclusions
Family-social support, level of education, marital status, and diabetes-related distress are the major determinants of patient experience of chronic illness care in people with type 2 diabetes.
SAFETY AND EFFICACY OF INSULIN PUMP IN IRANIAN PATIENTS WITH TYPE 1 DIABETES
Abstract
Background and Aims
To evaluate the safety and efficacy of insulin pump therapy in Iranian people with type 1 diabetes on an insulin regimen with multiple daily injections.
Methods
This study was an observational, non-interventional, prospective, multicentre survey with 6 month-follow-up time in subjects with type 1 diabetes on multiple daily insulin injections (MDI) for whom a continuous subcutaneous insulin infusion (CSII) therapy was recommended. Accu-Chek Combo system insulin pumps were used.
Results
A total of 20 patients were included. The mean age was 12.6 ± 0.61 years. The mean duration of diabetes was 5.7 ± 0.54 years. The mean HbA1c was 9.72±0.5% at baseline, whereas this figure was reported to be 7.58±0.28% by the end of the study. A mean absolute change of -2.14% was observed from baseline. The proportion of patients reaching the target of HbA1c<7% was 30% at month 6. The rate of major and nocturnal hypoglycemia was 41.7 (CI: 5.9 – 77.4) per 1,000 person-months.
Conclusions
Insulin pump therapy effectively reduced HbA1c in Iranian patients with type 1 diabetes with acceptable safety profile.